Meet Lori Grover

Lori L. Grover, OD, PhD

aoa 2019 head shot llg

Dr. Lori Grover is a nationally recognized clinician and educator in chronic vision impairment and its rehabilitation, and an advocate for improving population health and access to quality care for patients of all ages.  Dr. Grover is founder and Co-Director of the Center for Eye and Health Outcomes, established in 2018 at the Southern College of Optometry.  Center activities focused on health services research include current extramurally-funded collaborative investigation of the impacts of telehealth eye-related apps on health literacy and access to eye and vision care. She has served as Senior Vice President for Health Policy and Chief Compliance Officer at King-Devick Technologies, Inc. in Oakbrook, Illinois, where she oversaw international regulatory compliance efforts, developed health policy briefs and scientific manuscripts relative to the King-Devick Test (KDT) co-branded by Mayo Clinic and related medical  products, directed new medical device submission to the U.S. Food and Drug Administration (FDA), and successfully gained FDA medical device clearance.  She is a past Dean of the Pennsylvania College of Optometry at Salus University in Philadelphia where she oversaw development of the nation’s first two-year post graduate optometric residency in neuro-ophthalmic disease.  She was the inaugural Director of the Center for Translational Health Science and Associate Professor at Arizona State University College of Nursing and Health Innovation and School for the Science of Health Care Delivery in Phoenix.  Dr. Grover served as Assistant Professor and member of the medical staff in the Department of Ophthalmology at the Johns Hopkins University School of Medicine, Wilmer Eye Institute, in Baltimore.  While at Johns Hopkins, Dr. Grover served as Director of Research for the Office of Women in Science and Medicine (OWISM).  Dr. Grover received her PhD in Health Services Research and Policy from The Johns Hopkins Bloomberg School of Public Health and certificates in public health economics and public health informatics from the JHSPH Department of Health Policy and Management.

As a past recipient of a National Eye Institute/National Institutes of Health Clinical Scientist Training Grant award at Hopkins, she served as the Principle Investigator of a national research network investigating team strategies for, and patient access to, care for chronic vision impairment and health care.  Her clinical interests include clinical decision making and health information technology (HIT) applications in eye care – specifically,  the use of clinical decision support (CDS) systems in the treatment of chronic vision impairment and preventive care.  She writes often on the topics of evidence in clinical care, cost effectiveness analysis, and the value of comprehensive eye care to overall health.  Dr. Grover consults on promoting collaborative models for care focused on chronic health conditions and acquired injury involving vision loss, and is a frequent speaker on knowledge discovery and use of evidence in eye care to support development of policies that improve population health.  She was appointed to the Institute of Medicine’s  Committee on Public Health Approaches to Reduce Vision Impairment and Promote Eye Health in 2014.  Dr. Grover is an author of the 2016 National Academies of Science, Engineering, and Medicine (NASEM) report Making Eye Health a Population Health Imperative:  Vision for  Tomorrow.  Other publications include:  “Examination of the Patient with Low Vision”  in Albert and Jacobiec’s Principles and Practices in Ophthalmology, 3rd Edition; “Using OCT Angiography to Assess Diabetic Retinopathy and Diabetic Macular Edema” in Diabetic Eye Disease Consults:  Managing Patients with Diabetic Eye Disease;  “Treatment of Retrochiasmal Visual Field Defects” in Current Treatment Options in Neurology; and “Access To Health Care, Eye Care and Vision Rehabilitation Care For Older Adults with Chronic Vision Impairment in the United States” from The Johns Hopkins Bloomberg School of Public Health (please see site links for information on publications).

Dr. Grover’s involvement with health policy ranges from the state to the national level. Her current focus is on advancing evidence-based policies and protocols for eye health and care within the U.S. health care system.  In addition to advocacy in evidence-based primary eye and specialty care, her clinical specialty is in the diagnosis and treatment of chronic vision impairment, also known as vision rehabilitation.  Appointed to the Governor of Maryland’s Office of Health Care Reform and the Maryland Essential Health Benefits Committee, she fought for eye and vision care parity within the state exchanges as essential health benefits as part of the Affordable Care Act (ACA).  In 2018 Dr. Grover was elected to the Board of Trustees of the American Optometric Association (AOA).  She is a Past Chair of the AOA Vision Rehabilitation Section (VRS) where she served for eleven years at the national level leading advocacy, policy and practice in chronic vision impairment care (see professional experience for more information).  Dr. Grover was an inaugural member of the AOA’s Evidence Based Optometry Committee where she also serves as Methodologist.  She is an author of four AOA Evidence-Based Clinical Practice Guidelines.  She has served in multiple AOA state-affiliate associations, chairing and serving on key committees and promoting legislative and health policy initiatives. She is a member of the Vision Care Section (VCS) of the American Public Health Association, and led the formation of the Maryland Public Health Association’s (MdPHA) Eye and Vision Section in 2012.  Dr. Grover has held leadership positions in the Society for Medical Decision Making (SMDM) and AcademyHealth.  She is a past member of the board of directors of the Association of Schools and Colleges of Optometry (ASCO), and served as chair-elect of the Professional Development and Education Committee of the Association for Research in Vision and Ophthalmology (ARVO). She has served as grant reviewer for entities including the Centers for Disease Control and Prevention (CDC) and Department of Defense (DoD). Since 2017, she has represented the AOA on the CDC Vision Health Initiative (VHI) Strategic Planning Committee of the The Centers for Disease Control and Prevention.

Dr. Grover is a 1990 graduate of the Illinois College of Optometry in Chicago, and a 2012 graduate of the Johns Hopkins Bloomberg School of Public Health.   She is the 2004 ICO Alumna of the Year, 2006 recipient of the Don Aldrich Advocacy Award from the Mayor of Phoenix and Commission on Disability Issues, and a 2012 Distinguished Alumnus from Albion College.  In 2016 she received the President’s Award from the American Optometric Association.  She was elected to the National Academies of Practice (NAP) in 2009 and recognized as a senior fellow and distinguished practitioner.  She is a diplomate in public health and environmental vision and a fellow of the American Academy of Optometry (AAO).  She remains an active consultant for state, local, third party and professional groups on policy related to chronic vision impairment and its rehabilitation, and eye health outcomes in the health care continuum.  Dr. Grover is a frequent lecturer and international speaker on vision rehabilitation and the treatment of chronic vision impairment, shared clinical decision making, cost and comparative effectiveness, the use of evidence and outcomes in health care delivery, and high-value eye care  (see educational lectures and presentations for more information).

You can follow her on Facebook and Twitter.